Patents for a drug related to Ozempic have expired, so pharmaceutical companies are working to develop ‘generic’ versions. These are likely to be much cheaper. But how do they compare with Ozempic?
- ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
Our body fiercely protects the brain by holding onto things that help it and keeping harmful things out, such as toxins and bugs that can cause infection.
Ozempic generated A$21 billion of sales in 2023 alone. So how was it developed? And how are its new competitors, Mounjaro and Zepbound, different?
Contact Sebastian for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
-
- Joined
